| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.005 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |